These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1199 related articles for article (PubMed ID: 25377469)

  • 1. Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment.
    Cekic C; Day YJ; Sag D; Linden J
    Cancer Res; 2014 Dec; 74(24):7250-9. PubMed ID: 25377469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment.
    Young A; Ngiow SF; Gao Y; Patch AM; Barkauskas DS; Messaoudene M; Lin G; Coudert JD; Stannard KA; Zitvogel L; Degli-Esposti MA; Vivier E; Waddell N; Linden J; Huntington ND; Souza-Fonseca-Guimaraes F; Smyth MJ
    Cancer Res; 2018 Feb; 78(4):1003-1016. PubMed ID: 29229601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine A2A receptors intrinsically regulate CD8+ T cells in the tumor microenvironment.
    Cekic C; Linden J
    Cancer Res; 2014 Dec; 74(24):7239-49. PubMed ID: 25341542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer models.
    Leone RD; Sun IM; Oh MH; Sun IH; Wen J; Englert J; Powell JD
    Cancer Immunol Immunother; 2018 Aug; 67(8):1271-1284. PubMed ID: 29923026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-Thioguanine-loaded polymeric micelles deplete myeloid-derived suppressor cells and enhance the efficacy of T cell immunotherapy in tumor-bearing mice.
    Jeanbart L; Kourtis IC; van der Vlies AJ; Swartz MA; Hubbell JA
    Cancer Immunol Immunother; 2015 Aug; 64(8):1033-46. PubMed ID: 25982370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosuppressive mechanism via recruitment of myeloid-derived suppressor cells.
    Hosoi A; Matsushita H; Shimizu K; Fujii S; Ueha S; Abe J; Kurachi M; Maekawa R; Matsushima K; Kakimi K
    Int J Cancer; 2014 Apr; 134(8):1810-22. PubMed ID: 24150772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine influences myeloid cells to inhibit aeroallergen sensitization.
    Pei H; Linden J
    Am J Physiol Lung Cell Mol Physiol; 2016 May; 310(10):L985-92. PubMed ID: 27016586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin deficiency suppresses lymphoma growth in mice by modulating NK cells, CD8 T cells, and myeloid-derived suppressor cells.
    Han S; Jeong AL; Lee S; Park JS; Kim KD; Choi I; Yoon SR; Lee MS; Lim JS; Han SH; Yoon DY; Yang Y
    J Immunol; 2013 May; 190(9):4877-86. PubMed ID: 23530146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A
    Kjaergaard J; Hatfield S; Jones G; Ohta A; Sitkovsky M
    J Immunol; 2018 Jul; 201(2):782-791. PubMed ID: 29802128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic expression of IL-33 activates CD8(+) T cells and NK cells and inhibits tumor growth and metastasis in mice.
    Gao K; Li X; Zhang L; Bai L; Dong W; Gao K; Shi G; Xia X; Wu L; Zhang L
    Cancer Lett; 2013 Jul; 335(2):463-71. PubMed ID: 23499895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination.
    Kim A; Noh YW; Kim KD; Jang YS; Choe YK; Lim JS
    Exp Mol Med; 2004 Oct; 36(5):428-43. PubMed ID: 15557815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid suppressor cell depletion augments antitumor activity in lung cancer.
    Srivastava MK; Zhu L; Harris-White M; Kar UK; Huang M; Johnson MF; Lee JM; Elashoff D; Strieter R; Dubinett S; Sharma S
    PLoS One; 2012; 7(7):e40677. PubMed ID: 22815789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors.
    Beavis PA; Divisekera U; Paget C; Chow MT; John LB; Devaud C; Dwyer K; Stagg J; Smyth MJ; Darcy PK
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14711-6. PubMed ID: 23964122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
    Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH
    Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of adenosine A2A receptor enhances CD8
    Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
    Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A2A adenosine receptor protects tumors from antitumor T cells.
    Ohta A; Gorelik E; Prasad SJ; Ronchese F; Lukashev D; Wong MK; Huang X; Caldwell S; Liu K; Smith P; Chen JF; Jackson EK; Apasov S; Abrams S; Sitkovsky M
    Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13132-7. PubMed ID: 16916931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
    Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
    J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse CD8
    Li Z; Wu Y; Wang C; Zhang M
    Cancer Immunol Immunother; 2019 Aug; 68(8):1303-1315. PubMed ID: 31278476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Antagonist of the Immune Checkpoint Protein Adenosine A2a Receptor Restores Tumor-Infiltrating Lymphocyte Activity in the Context of the Tumor Microenvironment.
    Mediavilla-Varela M; Castro J; Chiappori A; Noyes D; Hernandez DC; Allard B; Stagg J; Antonia SJ
    Neoplasia; 2017 Jul; 19(7):530-536. PubMed ID: 28582704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors.
    Kerkar SP; Goldszmid RS; Muranski P; Chinnasamy D; Yu Z; Reger RN; Leonardi AJ; Morgan RA; Wang E; Marincola FM; Trinchieri G; Rosenberg SA; Restifo NP
    J Clin Invest; 2011 Dec; 121(12):4746-57. PubMed ID: 22056381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.